 Prognostic variables patients diffuse large-cell lymphoma MACOP-B twenty-six patients diffuse large-cell lymphoma methotrexate leucovorin doxorubicin cyclophosphamide vincristine prednisone bleomycin MACOP-B April June Univariate multivariate analyses overall survival September end point independent negative predictors survival presence symptoms involved lymph node extranodal site variables burden age variable patient ability treatment variable relative risk simple predictive formula approximate percentage chance survival years number predictive variables present predictors significant multivariate analysis patients complete response